A new trading day began on Friday, with Tandem Diabetes Care Inc (NASDAQ: TNDM) stock price down -3.97% from the previous day of trading, before settling in for the closing price of $37.49. TNDM’s price has ranged from $21.85 to $53.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 21.47% over the past five years. Meanwhile, its annual earnings per share averaged 50.60%. With a float of $65.18 million, this company’s outstanding shares have now reached $65.65 million.
Let’s look at the performance matrix of the company that is accounted for 2400 employees. In terms of profitability, gross margin is 43.69%, operating margin of -13.72%, and the pretax margin is -12.65%.
Tandem Diabetes Care Inc (TNDM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Tandem Diabetes Care Inc is 0.75%, while institutional ownership is 112.73%. The most recent insider transaction that took place on Nov 21 ’24, was worth 941,400. In this transaction Director of this company sold 30,000 shares at a rate of $31.38, taking the stock ownership to the 165,190 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Director sold 10,000 for $30.00, making the entire transaction worth $300,000. This insider now owns 195,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.60% per share during the next fiscal year.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Here are Tandem Diabetes Care Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.94, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Inc (NASDAQ: TNDM) saw its 5-day average volume 0.91 million, a negative change from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 60.65%. Additionally, its Average True Range was 1.79.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 43.28%, which indicates a significant decrease from 60.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.12% in the past 14 days, which was lower than the 52.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.97, while its 200-day Moving Average is $39.16. Nevertheless, the first resistance level for the watch stands at $36.83 in the near term. At $37.66, the stock is likely to face the second major resistance level. The third major resistance level sits at $38.31. If the price goes on to break the first support level at $35.35, it is likely to go to the next support level at $34.70. The third support level lies at $33.87 if the price breaches the second support level.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
With a market capitalization of 2.36 billion, the company has a total of 65,677K Shares Outstanding. Currently, annual sales are 747,720 K while annual income is -222,610 K. The company’s previous quarter sales were 243,970 K while its latest quarter income was -23,250 K.
